Requires Adobe Acrobat ReaderRequires Adobe Acrobat ReaderData Tables
| View HTML | View PDF | |
|---|---|---|
Section XIII | ||
| 13.1a | Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1999 to 2008 | (48 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 13.1b | Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Inactive Waitlist Patients, 1999 to 2008 | (48 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 13.2 | Time to Transplant, 1999 to 2008 New Heart-Lung Waiting List Registrations | (78 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| State of Center | ||
| 13.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Heart-Lung Waiting List | (72 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| State of Center | ||
| 13.4 | Transplant Recipient Characteristics, 1999 to 2008 Heart-Lung Recipients | (43 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 13.5 | Incidence of Transplant, 1999 to 2008 Heart-Lung Transplants per 1 Million Population | (46 k) |
| 13.6a | Immunosuppression Use for Induction, 1999 to 2008 Recipients with Heart-Lung Transplants | (28 k) |
| 13.6b | Immunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Heart-Lung Transplants | (30 k) |
| 13.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Heart-Lung Transplants | (29 k) |
| 13.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Heart-Lung Transplants | (28 k) |
| 13.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Heart-Lung Transplants | (30 k) |
| 13.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung Transplants | (30 k) |
| 13.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung Transplants | (32 k) |
| 13.6h | Persistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Heart-Lung Transplants | (37 k) |
| 13.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Heart-Lung Transplants | (32 k) |
| 13.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Heart-Lung Transplantation | (83 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Previous Transplant | ||
| Age | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Diagnosis | ||
| State of Center | ||
| 13.8 | Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (41 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 13.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.10 | Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (47 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 13.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.12 | Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (41 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| State of Center | ||
| 13.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.14 | Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years | (47 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| State of Center | ||
| 13.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants | (22 k) |
| 13.16 | Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1999 to 2007 | (42 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 13.17 | Transplants by State and Transplant Center, 1999 to 2008 Heart-Lung | (57 k) |
